Skip to search formSkip to main contentSkip to account menu

saroglitazar

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A Prospective, Multicentre, Single Arm Clinical Study to Evaluate the Effect of Saroglitazar on Non High-Density Lipoprotein Cholesterol in Patients with Diabetic Dyslipidemia Inadequately Controlled…
Objective: Diabetic dyslipidemia is highly atherogenic as it is associated with high triglyceride (TG), high small dense low… 
2019
2019
Antiretroviral drug-induced endothelial dysfunction is improved by dual PPARα/γ stimulation in obesity.
Review
2017
Review
2017
Saroglitazar: A New Drug to Treat Diabetic Hypertriglyceridemia
Dyslipidemia alone has been considered as one of the major modifiable risk factor for cardiovascular diseases (CVD) accounting… 
2016
2016
Quantitative determination of saroglitazar, a predominantly PPAR alpha agonist, in human plasma by a LC-MS/MS method utilizing electrospray ionization in a positive mode.
A sensitive LC-MS/MS method was developed and validated for quantitation of saroglitazar using turboion spray interface with… 
2016
2016
A Novel Method Enabling the Use of Small Muscle Samples to Identify Insulin Effects on Akt 2 and AS 160 Subcellular Localization
SUBMISSION DEADLINE: OCTOBER 1, 2016 TARGETED AUDIENCE • Clinicians and allied health professionals with an interest in nutrition… 
2015
2015
From 'Make in India' to 'Made in India': the saroglitazar story.
2015
2015
STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR ESTIMATION OF SAROGLITAZAR IN BULK AND TABLET DOSAGE FORM
A simple, precise, rapid and reproducible stability indicating RP HPLC method was developed and validated for the determination… 
Review
2014
Review
2014
Saroglitazar, a novel cardiometabolic agent for diabetic dyslipidemia – A Review
Diabetes mellitus is a worldwide prevalent chronic disease with a significant disease burden. The associated dyslipidemia adds to… 
2014
2014
METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF SAROGLITAZAR IN BULK AND PHARMACEUTICAL DOSAGE FORM BY RP-HPLC
A simple, sensitive and rapid reverse phase high performance liquid chromatographic method was developed for the estimation of… 
2014
2014
Diabetic Dyslipidemia - Role of Saroglitazar
‘Diabetic dyslipidemia’ (combination of raised triglyceride levels, raised small-dense Low-density lipoprotein particles and low… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)